Glenmark Pharmaceuticals Ltd. is a research-driven, global, integrated pharmaceutical company. A key player in the discovery of new molecules, both NCEs (New Chemical Entity) and NBEs (New Biological Entity), Glenmark has offices in 20 countries and 16 manufacturing facilities across 5 countries. Glenmark maintains a large presence in branded generics throughout emerging markets including India. Its subsidiary, Glenmark Generics Ltd. is a fast growing and robust US generics business, which markets APIs to regulated and semi-regulated countries.